Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-110016
Filing Date
2024-09-27
Accepted
2024-09-27 16:17:16
Documents
1
Period of Report
2024-09-25

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3809
  Complete submission text file 0000950170-24-110016.txt   5181
Mailing Address 10240 BUBB ROAD CUPERTINO CA 95014
Business Address 10240 BUBB ROAD CUPERTINO CA 95014 4087771417
DURECT CORP (Issuer) CIK: 0001082038 (see all company filings)

EIN.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 142 TEMPLE STREET SUITE 205 NEW HAVEN CT 06510
Business Address
Farfel Gail M (Reporting) CIK: 0001614780 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-31615 | Film No.: 241335101